Acellular perfussis vaccine (Infanrix®-DTPa; SB-3). A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection

Drugs

Volumn 52, Issue 2, 1996, Pages 254-275

  Patel, S S ^a   Wagstaff, A J ^a   Annunziato, P W ^a   Bernstein, D I ^a   Bernstein, H H ^a   Conway, S P ^a   Decker, M D ^a   Englund, J A ^a   Mizushima, Y ^a   Van den Oever, R ^a   Preston, N W ^a   Rothstein, E P ^a   Salmaso, S ^a   Schmitt, H J ^a   Simon, I ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; PERTUSSIS VACCINE; INACTIVATED VACCINE;

ANTIBODY RESPONSE; BORDETELLA PERTUSSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYING; DIPHTHERIA; DRUG EFFICACY; DRUG TOLERABILITY; EDEMA; ERYTHEMA; FEVER; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFANT; INJECTION PAIN; INJECTION SITE; INTRAMUSCULAR DRUG ADMINISTRATION; IRRITABILITY; MAJOR CLINICAL STUDY; META ANALYSIS; PERTUSSIS; REVIEW; SEROCONVERSION; SUBCUTANEOUS DRUG ADMINISTRATION; TETANUS; VACCINATION; CLOSTRIDIUM TETANI; COMPARATIVE STUDY; CORYNEBACTERIUM DIPHTHERIAE; IMMUNOLOGY;

BORDETELLA PERTUSSIS; HAEMOPHILUS; HAEMOPHILUS INFLUENZAE SEROTYPE B;

BORDETELLA PERTUSSIS; CLOSTRIDIUM TETANI; CORYNEBACTERIUM DIPHTHERIAE; DIPHTHERIA; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; HUMANS; INFANT; TETANUS; VACCINES, INACTIVATED; WHOOPING COUGH;

EID: 0029657943     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199652020-00010     Document Type: Review

References (0)